Plasma levels of p53 protein were examined by an enzyme linked immunos
orbent assay in 184 patients enrolled in a colonoscopy study, The mean
levels among 47 individuals with normal colonoscopic examinations and
no prior history of colonic neoplasia (0.12 ng/ml) and among 61 indiv
iduals with normal colonoscopic examinations and a prior history of co
lonic neoplasia (0.09 ng/ml) were similar. However, the mean levels am
ong 54 individuals with newly diagnosed colonic adenomas (0.44 ng/ml)
and 22 individuals with newly diagnosed colonic carcinomas (0.55 ng/ml
) were statistically Significantly elevated compared to the normal con
trols (P < 0.02). Among these tumor patients, the plasma levels tended
to increase with increasing adenoma size and with increasing carcinom
a stage, although these trends were not statistically significant. Def
ining a significant positive plasma level as any value greater than te
n times background, the percentage of positive samples increased from
4% in the controls to 20% in the adenoma cases to 32% in the carcinoma
cases, These results demonstrate that plasma p53 protein levels are e
levated in a subgroup of individuals with colonic neoplasia.